Literature DB >> 17480058

Oxidation of methionine residues in recombinant human interleukin-1 receptor antagonist: implications of conformational stability on protein oxidation kinetics.

Renuka Thirumangalathu1, Sampathkumar Krishnan, Pavel Bondarenko, Margaret Speed-Ricci, Theodore W Randolph, John F Carpenter, David N Brems.   

Abstract

Oxidation of methionine residues is involved in several biochemical processes and in degradation of therapeutic proteins. The relationship between conformational stability and methionine oxidation in recombinant human interleukin-1 receptor antagonist (rhIL-1ra) was investigated to document how thermodynamics of unfolding affect methionine oxidation in proteins. Conformational stability of rhIL-1ra was monitored by equilibrium urea denaturation, and thermodynamic parameters of unfolding (DeltaGH2O, m, and Cm) were estimated at different temperatures. Methionine oxidation induced by hydrogen peroxide at varying temperatures was monitored during "coincubation" of rhIL-1ra with peptides mimicking specific regions of the reactive methionine residues in the protein. The coincubation study allowed estimation of oxidation rates in protein and peptide at each temperature from which normalized oxidation rate constants and activation energies were calculated. The rate constants for buried Met-11 in the protein were lower than for methionine in the peptide with an associated increase in activation energy. The rate constants and activation energy of solvent exposed methionines in protein and peptide were similar. The results showed that conformational stability, monitored using the Cm value, has an effect on oxidation rates of buried methionines. The rate constant of buried Met-11 correlated well with the Cm value but not DeltaGH2O. No correlation was observed for the oxidation rates of solvent-exposed methionines with any thermodynamic parameters of unfolding. The findings presented have implications in protein engineering, in design of accelerated stability studies for protein formulation development, and in understanding disease conditions involving protein oxidation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17480058     DOI: 10.1021/bi700321g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Stability of protein pharmaceuticals: an update.

Authors:  Mark Cornell Manning; Danny K Chou; Brian M Murphy; Robert W Payne; Derrick S Katayama
Journal:  Pharm Res       Date:  2010-02-09       Impact factor: 4.200

2.  Rapid assessment of oxidation via middle-down LCMS correlates with methionine side-chain solvent-accessible surface area for 121 clinical stage monoclonal antibodies.

Authors:  Rong Yang; Tushar Jain; Heather Lynaugh; R Paul Nobrega; Xiaojun Lu; Todd Boland; Irina Burnina; Tingwan Sun; Isabelle Caffry; Michael Brown; Xiaoyong Zhi; Asparouh Lilov; Yingda Xu
Journal:  MAbs       Date:  2017-02-14       Impact factor: 5.857

3.  Probing bis-Fe(IV) MauG: experimental evidence for the long-range charge-resonance model.

Authors:  Jiafeng Geng; Ian Davis; Aimin Liu
Journal:  Angew Chem Int Ed Engl       Date:  2015-01-28       Impact factor: 15.336

4.  Effect of arginine on pre-nucleus stage of interferon beta-1b aggregation.

Authors:  Ahmad Fazeli; Mohadeseh Haji-Abdolvahab; Seyed Abbas Shojaosadati; Huub Schellekens; Khosro Khalifeh; Ali Akbar Moosavi-Movahedi; Mohammad Reza Fazeli
Journal:  AAPS PharmSciTech       Date:  2014-08-21       Impact factor: 3.246

5.  Effect of Chemical Oxidation on the Higher Order Structure, Stability, Aggregation, and Biological Function of Interferon Alpha-2a: Role of Local Structural Changes Detected by 2D NMR.

Authors:  Dinen D Shah; Surinder M Singh; Krishna M G Mallela
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

Review 6.  Non-Arrhenius protein aggregation.

Authors:  Wei Wang; Christopher J Roberts
Journal:  AAPS J       Date:  2013-04-25       Impact factor: 4.009

7.  Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.

Authors:  Tia Estey; Christina Vessely; Theodore W Randolph; Ian Henderson; Latoya Jones Braun; Rajiv Nayar; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Kinetic study of beta-amyloid residue accessibility using reductive alkylation and mass spectrometry.

Authors:  Irina Ramos; Dan Fabris; Wei Qi; Erik J Fernandez; Theresa A Good
Journal:  Biotechnol Bioeng       Date:  2009-09-01       Impact factor: 4.530

9.  Aggregation of a monoclonal antibody induced by adsorption to stainless steel.

Authors:  Jared S Bee; Michele Davis; Erwin Freund; John F Carpenter; Theodore W Randolph
Journal:  Biotechnol Bioeng       Date:  2010-01-01       Impact factor: 4.530

10.  A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies.

Authors:  Jan Stracke; Thomas Emrich; Petra Rueger; Tilman Schlothauer; Lothar Kling; Alexander Knaupp; Hubert Hertenberger; Andreas Wolfert; Christian Spick; Wilma Lau; Georg Drabner; Ulrike Reiff; Hans Koll; Apollon Papadimitriou
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.